The mouse fim-1 gene encodes two cytoplasmic serinethreonine-specific protein kinases. The gene has been found to be activated (overexpressed) by retroviral insertion in hematopoietic tumors in mice. Transgenic mice that overexpress fim-1 (Ep-Pim-1) have a low incidence of spontaneous T-cell lymphomas and an increased susceptibility to Moloney murine leukemia virus and N-ethyl-N-nitrosourea-induced lymphomas. Apart from a slight enlargement of the spleen, no abnormalities were found in prelymphomatous transgenic mice. Inactivation of the Pim-I gene in the germline of mice resulted in mice with a ZM-1 IS A HIGHLY conserved gene'-5 that was origi-P nally discovered as a common proviral insertion site in T-cell lymphomas in mice.6 Pim-1 was subsequently shown to be involved in the generation of B-cell lymphoma^,^^' and erythroleukemias' as well. Characterization of the mouse gene showed an open-reading frame encoding a protein with all of the hallmarks of a protein kinase.' The gene gives rise to two primary translation products by alternative initiation at CUG and AUG, yielding proteins of 44 and 34 Kd. Both were shown to exhibit protein-serine/threonine kinase activity." Relatively high Pim-1 expression is found in hematopoietic tissues such as thymus, spleen, and fetal liver, but also embryonic stem (ES) cells and testes. Expression is highly inducible by growth factors such as interleukin (1L)-2, IL-3, and granulocyte-macrophage colony-stimulating factor (GM-CSF)."-" Functionally, this is in line with the very short half-lives of both mRNA'' and protein." These observations, in combination with the fact that overexpression in mice contributes to leukem~genesis,~~',~~'~~'~ indicate that Pim-1 fulfills a regulatory role in the hematopoietic compartment. However, myeloid and lymphoid cells that overexpress Pim-1 from the Ep-Pim-I transgene did not show any marked alterations in growth behavior in vitro, such as factor independence, even if combined with an activated c-myc gene (J. Domen, E. Spooncer, and T.M. Dexter, unpublished results), a gene combination that shows dramatic synergistic effects in vivo.' However, this does not exclude the involvement of Pim-1 in growth factor signaling, since effects may only become apparent under specific conditions. The availability of Pim-1 null mutant mice obtained via homologous recombination in ES cells'' has allowed us to investigate further the involvement of Pim-I in growth factor responses of factor-dependent hematopoietic cells. We concentrated on bone marrow-derived mast cells (BMMC) because they depend on IL-3,I9 a factor known to induce Pim-1 mRNA. They also respond to other growth factors, which allows investigation of the involvement of Pim-1 in a series of responses to growth factors, whose activities are not limited to mast cells, but which also play a role in lymphoid proliferation and differentiation.
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MATERIALS AND METHODS

Pim-1 mutant mice.
Generation of the null mutant mice by homologous recombination in ES cells will be described else- where.I8 These null mutants, in which the first three exons of Pim-1 have been replaced by a 3-phosphoglycerate kinase (PGK)-neo cassette, have no Pim-1 protein expression, as shown below. The mice used were outbred mice, obtained by crossing 129/OLA and BALB/c mice, followed by back-crossing with 129/0LA. We also used mice derived from an independent targeting event, described previously.2o This null mutation was present in inbred 129/0LA mice. Ep-Pim-1 transgenic mice have been described previously. '6 The transgene consists of a genomic Pim-1 clone with two copies of the Ig E p enhancer upstream and a Moloney long terminal repeat (LTR) in the 3' untranslated region. The transgene was introduced into (CBA/BrA X C57BL/LiA)FI zygotes and the resulting transgenic mice were back-crossed with (CBA/BrA X C57BL/LiA)F I, C57BL/LiA, or C57BL/6 mice. BMMC cultures were initiated by flushing bone marrow cells from femurs (and sometimes tibiae) into RPMI1640 plus 15% fetal calf serum (FCS) plus 5 X lo-' mol/L P-mercaptoethanol plus 20% WEHI-3b-conditioned medium (CM) as a source of IL-3. Cultures were initiated at 1 X IO6 cells/ mL. Nonadherent cells were subcultured weekly at 2 X lo5 cells/ mL. After 4 weeks, the cultures contained an almost homogeneous population of BMMC, as judged from May-Grunwald/Giemsa-or Alcian blue/safranin-0-stained (BDH, Poole, UK) cytospins.
Short-term growth factor stimulations. BMMC from established cultures (>4 weeks in culture) were collected by centrifugation, washed three times in medium without IL-3, and resuspended (at twice the final cell concentration) in RPMI1640 plus 5% or 15% FCS plus 5 X mol/L 0-mercaptoethanol. One hundred micro- Immunoprecipitation with polyclonal anti-Pim-1 c-terminal peptide serum and in vitro kinase assay were performed as described previously" except that freeze-thaw lysates of equal numbers of cells were made in 25 mmol/L triethanolamine/HCI, pH 7.5,30 mmol/L NaC1,S mmol/L MgCl,, 14 mmol/L 0-mercapthoethanol, I % Aprotinin, I mmol/L phenylmethylsulfonylfluoride, 1 mmol/L Leupeptin, 1 pg/mL soybean trypsin inhibitor, and 5 mmol/L CHAPS was used instead of I% Nonidet P40. Reagents were purchased from Boehringer Mannheim (Mannheim, Germany), except NP40 (BDH).
Nematode infections. Mice were infected with 700 rat-adapted Nippostrongylus brasiliensis stage 3 larvae by subcutaneous injection. At day 13, the infected mice and noninfected controls were killed and "swiss roll" jejunal sections were made and stained with Alcian blue and safranin-0 at a low pH essentially as de~cribed.'~
RESULTS
Analysis of expression levels.
Growth factor responses of BMMC. BMMC cultures were initiated from bone marrow of mice either homozygous for the Pim-1 null allele or their wild-type littermates (Fig 1) . Whereas no reproducible difference between the two groups of cultures is observed in the initial, mixed cell population, a marked difference in the growth response to IL-3 becomes apparent once a morphologically homogeneous mast-cell population is obtained. Wild-type BMMC grew well on IL-3, while all of the homozygous mutant BMMC grew poorly. After 4 weeks in culture, the growth seen in Pim-1 -deficient BMMC cultures was 44% f 13% (mean k SD; n = 1 1) of that seen in cultures derived from sibling wild-type mice. This remained consistent over long periods of time, as is illustrated in Fig 1, which shows the establishment and growth of a further set of Pim-1 -deficient and wild-type cultures. The doubling time for established cultures over a 3-to 5-week period was 97 f 22 hours (mean k SD, n = 4) for Pim-I-deficient cultures and 58 f 13 hours (n = 5) for wild-type cultures. There are no differences in viability of the cells growing on IL-3. In wild-type cultures, Higher levels of IL-3 cannot compensate for the reduced maximum growth rate of BMMC carrying the Pim-I null allele. This effect was independent of the source of IL-3 as the same results were obtained with WEHI-3b-CM24 (Fig  2A) , purified recombinant IL-3 ( Fig 2B) and X63-IL-3-CM21 ( Fig 2C) . Interestingly, cultures heterozygous for the Pim-1 null allele grew at intermediate rates, which shows a dosage effect of Pim-1 on IL-3-mediated growth (Fig 2A) .
Two interpretations can be given to these results: (1) Pim- . . . .). The cultures were incubated with the indicated amounts of X63-IL-3-CM as a source of IL-3. Initial density was 2 X IO' cells/mL and the cells were allowed to grow for 3 days. The experiment was performed in duplicate, SDs are shown when larger than the marker symbols. (D) As (C), but the cells were stimulated with soluble recombinant rat stem cell factor-1 64 (rrSCF-l64).*"
or S F withdrawal of both growth factors leads to cell death (Fig 3) . Cell death induced in hematopoietic cells by lack of growth factor stimulation is usually through apoptosis.'* This is also the case for these cultures, as judged from the appearance of oligonucleosome-length DNA fragments and the delay of cell death in the presence of cycloheximide (data not shown), both of which are hallmarks for apoptosk2' Interestingly, cells derived from Pim-1-deficient BMMC cultures die more slowly upon removal of IL-3 than wild-type BMMC (Fig 3A and B) . This difference is less clear when cells are deprived of SF (Fig 3B) . In the latter case, cell death also occurs more rapidly. When BMMC cultures were established from mice overexpressing Pim-1 from the Ep-Pim-1 transgene, a clear difference in the growth was noted between cultures derived from B.CBA mice (transgenics and sibling wild types) and cultures derived from 129/OLA and 129/OLA x BALB/c mice (null mutants and sibling wild types). The B.CBA cultures grew relatively poorly and contained more dead cells. However, when BMMC carrying the EpPim-1 transgene were compared with their wild-type littermates, no clear differences were apparent. Despite the overexpression, the cells remained dependent on IL-3 and did not grow faster than cells derived from wild-type littermates. Both sets of cultures contained similar amounts of dead cells when growing on IL-3, with 87% k 9% of the cells alive in transgenic cultures, and 84% & 10% alive in wild-type cultures (means k SD; 15 cell counts on cultures from three different mice per group). Transgenic and wild-type cultures did not clearly differ in their response to SF (data not shown). Responses of BMMC IO growth factor combinations. Subsequently, we determined the effects of stimulation with more than one growth factor. Several growth factors can enhance the IL-3-mediated proliferative response." BMMC, wild-type or homozygous with respect to the Pim-1 null allele, were stimulated with IL-2, IL-3, IL-4, IL-5 (X63-CM), or IL-9. Without added growth factors the cells die, albeit less rapidly in cultures lacking Pim-l than in wildtype cultures (Fig 4) . IL-2 (and IL-5, data not shown), fail to induce growth, showing that stimulation by X63-CM is specific for the interleukin construct with which they were transfected. IL-4 and IL-9 alone also do not induce growth, although they do retard cell death. This is most apparent in the wild-type culture, where cell death occurs faster. In the presence of IL-3, both factors reproducibly induce a growth response, which appears not to be influenced by the presence or absence of Pim-I. IL-3 alone induces growth as before, ie, stronger in the wild-type culture. This response cannot be increased in either culture by doubling the amount of IL-3 used. The responses ofcultures overexpressing Pim-l did not differ significantly from that of wild-type cultures (data not shown).
Furthermore, when BMMC were treated simultaneously with IL-3 and SF (Fig 5) , they exhibited the same growth rate as with SF alone, but Pim-l-deficient cells grew to higher densities, something which has not been observed in single-factor stimulations. Cells from cultures overexpressing Pim-I grew less well than wild-type cells under these conditions. This again confirms that Pim-1 specifically influences certain aspects of the IL-3 response.
Pim-1 expression levels in mulan~ mast cells. To ascertain that the differences observed in growth induced by IL-3 correlated with the presence of Pim-I, we quantitated the Pim-1 mRNA and protein levels (Fig 6) . We found high Pim-l mRNA expression in wild-type BMMC, comparable to the levels seen in lymphocytes. Even higher levels are seen in BMMC carrying the Ep-Pim-1 transgene (transgenic mRNA is characterized by a slightly lower mobility '6) . No mRNA WBS found in BMMC from homozygous mutant mice, while intermediate levels were present in heterozygous BMMC (Fig 6A) . To verify that the protein levels correlate with the mRNA levels, we determined Pim-1-specific kinase activity. We failed to detect any autophosphorylation of Pim-l in lysates from BMMC homozygous for the For personal use only. on October 3, 2017. by guest www.bloodjournal.org From hours of stimulation in a kinase assay, cells grown on SF alone contain only low levels of the Pim-I proteins. When both growth factors are combined, the levels are similar to those seen in cells grown on IL-3 alone, indicating that SF is not able to downmodulate Pim-I induction by IL-3. Neitherdid combined stimulations with IL-3 and IL-4 or IL-3 and IL-9 lead to differences in Pim-l protein level.
BMMC resemble the mucosal-type mast cells present in mice. When these were quantitated in Alcian blue-stained midjejunal sections (Table l), no significant differences were observed between Pim-I null mutant and wild-type mice. To investigate whether the impaired 1L-3-induced proliferation would Mucosal-type mast cells in vivo. compromise the mast-cell response in vivo, homozygous targeted and wild-type mice were infected with the nematode parasite N brasiliensis, to which a partially IL-3-dependent mast-cell response is mounted, resulting in a 25-to 40-fold increase in the number of intestinal mast cells in BALB/c m i~e . '~. '~ Quantitation of serum IgE levels (not shown) and mast cells in jejunal sections (Table 1) showed a normal response to the infection. No differences were observed between the two groups of mice.
DISCUSSION
The data presented here show that BMMC lacking Pim-1 have an aberrant response to IL-3 in vitro. The response of other factors tested (IL-4, IL-9, and SF) is not detectably altered in the absence of Pim-I. The IL-3 response of BMMC overexpressing Pim-1 does not differ significantly from that of wild-type cultures. Combined stimulation with IL-3 and SF allows null-mutant cultures to reach higher cell densities than wild-type cultures, while transgenic cultures grow to lower densities than wild-type cultures. The difference in cell death observed when the cells are growth factordeprived is intriguing, but it cannot explain the differences observed in IL-3-induced proliferation, since there are no clear differences in the percentage of dead cells present in IL-3-stimulated growing or resting cultures. The difference in apoptosis may be caused by a difference in cycling speed. It has been noted before that aberrant cell-cycle control, as, for example, caused by constitutive c-myc expression, can lead to accelerated apoptosis when dependent cells are deprived of The virtual absence of Pim-l expression in wild-type BMMC maintained on SF is interesting, explaining the lack of difference in this response between null-mutant and wild-type cultures. This implies a role for Pim-1 as a modulator of the IL-3 response.
IL-3. produced by activated T cells, keratino~ytes,'~ activated mast cell^,^'*^' and stroma ~e l l s , 3~ is a potent growth factor, acting on a wide range of myeloid and lymphoid cells. It can stimulate both self-renewal and differentiation of multipotent cells into all myeloid lineages. As a mitogen, it is generally more powerful for early progenitor cells than for more mature cells. However, the factor is also capable of potentiating some mature cell function^.^' Infusion of IL-3 into mice leads to an increase in myeloid progenitors in, and size of, the spleen, while bone marrow cellularity dec r e a s e~.~~.~' Only a modest increase is found in mature peripheral blood cells. Apart from stimulating myeloid cells, IL-3 has also been reported to be able to stimulate lymphoid cells in ~itro.'~.~' However, it is unclear whether this is important in vivo. 38 While it is unknown what the consequences ofabsence of IL-3 in vivo are, variations in the response of different mouse strains to IL-3 have been documented. Differences between inbred mouse strains described in the literature include a IO-fold variation in the induction ofsmall mast cells after infusion of IL-3,34 while it has also been reported that some strains of mice are virtually unresponsive to IL-3 in colony assays.39 Such variations between strains and mutants has also been reported for IL-3-induced mast cell growth in vitro. 40 We also find differences in the IL-3 response between wild-type mice of the strains used to overexpress Pim-I, whose genetic background is mainly C57BL/6-derived, and which performs rather poorly when compared with the strain used to inactivate Pim-I, which is present on a 129/OLA background and which grows well. However, the effects attributed to Pim-1 can be shown in comparisons of littermates that only differ in one, molecularly defined, lesion in the Pim-1 gene, and consequently the effects described here do not reflect differences in the genetic background, but have to be attributed solely to Pim-1. The variations seen between mouse strains with an apparently normal hematopoietic system are in accordance with our finding that, although Pim-1 appears to be a modulator of the IL-3 response, mice lacking Pim-l do not show any obvious hematopoietic abnormalities in vivo and are even able to mount an apparently normal mast-cell response when challenged with nematode parasites. This can be explained by the fact that multiple growth factors act in vivo. For example, for the nematode-induced mast cell response, IL-4 has also been shown to be a major factor.23 In addition, it is important to stress that, as the BMMC cultures show, the capacity to respond to IL-3 in the absence of Pim-1 is only reduced, not absent. The consequences of the absence of Pim-1 for the IL-3 response did not differ between inbred (129/01a, Fig 2B through D) and outbred (129/01a X BALB/c, other figures) mice. The latter mice are all derived from the targeting event described by Laird et a1," and the inbred 129/01a null mutant mice were generated from the double-targeted ES cells described previously.2o
Abrogation of IL-3 dependence of mast cells has been accomplished in a nonautocrine fashion by introducing tyrosine kinase oncogenes such as ~-ubl,~'fms, src, and trk42 into mast cells. Introduction of an activated H-rus gene into mast cells43 led to an abrogation of IL-3 dependence in an autocrine fashion. Abrogation of IG3 dependence cannot be accomplished by overexpressing Pim-1 in BMMC.
The reversal of the growth phenotype when cells are stimulated simultaneously with IL-3 and SF is somewhat puzzling, as proliferation in response to SF is normal in Pim-1-deficient BMMC and does not involve induction of Pim-1 expression in wild-type BMMC. Possibly, the mode of action of Pim-1 on IL-3-induced proliferation is dependent on the state of activation of certain other signal transduction pathways, eg, that of SF. In this way, the proteins could contribute to the integration of different growth factor signals. Such a function would be compatible with the subtle effects caused by aberrant Pim-1 expression. Linkage between IL-3 and SF stimulation has been noted before. IL-3 stimulation can lead to downregulation of c-kitU (SFreceptor), while incubation of human CD34+ hematopoietic progenitor cells with c-kit anti-sense oligonucleotides specifically inhibits granulocyte-macrophage colony formation induced by IL-3, but not by GM-CSF.45 The observation that some of the specific tyrosine-phosphorylated target proteins are shared by both pathways46 is in line with this notion. BMMC stimulated with SF differentiate from mucosal-type mast cells toward connective tissue-type mast cells. When both stimuli are combined, IL-3 appears to be dominant:' as is the case for the induction of Pim-1. The results presented here suggest that Pim-1 may be involved in integrating the SF and IL-3 responses. Formal proof for such a function will have to come from biochemical dissection of these responses. Studies along those lines are being pursued.
In view of the involvement of Pim-1 in T-and B-cell lymphomagenesis, it can be expected that its function is not limited to the IL-3 signal transduction pathway. In line with this notion, we have recently shown that aberrant expression of the gene can have similar effects on the responses of B-lymphoid cells."'
